INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 161 filers reported holding INTERSECT ENT INC in Q2 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $3,971,000 | +14.1% | 123,514 | 0.0% | 0.05% | 0.0% |
| Q4 2018 | $3,481,000 | -27.6% | 123,514 | -26.2% | 0.05% | -19.4% |
| Q3 2018 | $4,811,000 | -24.2% | 167,333 | -1.2% | 0.06% | -29.5% |
| Q2 2018 | $6,345,000 | +45.4% | 169,435 | +52.6% | 0.09% | +31.3% |
| Q1 2018 | $4,364,000 | +7.0% | 111,033 | -11.8% | 0.07% | +13.6% |
| Q4 2017 | $4,079,000 | -10.8% | 125,890 | -14.2% | 0.06% | -9.2% |
| Q3 2017 | $4,571,000 | +10.5% | 146,726 | -0.9% | 0.06% | +3.2% |
| Q2 2017 | $4,137,000 | +32.9% | 147,998 | -18.5% | 0.06% | +18.9% |
| Q1 2017 | $3,114,000 | +56.0% | 181,550 | +10.0% | 0.05% | +35.9% |
| Q4 2016 | $1,996,000 | -23.6% | 165,000 | 0.0% | 0.04% | -15.2% |
| Q3 2016 | $2,614,000 | – | 165,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
| First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
| HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
| Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
| Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
| PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
| Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |